Altamira Therapeutics Stock Analysis

Altamira Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.25. Some equities with similar Price to Book (P/B) outperform the market in the long run. Altamira Therapeutics last dividend was issued on the 1st of May 2019. The entity had 1:20 split on the 13th of December 2023. Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Altamira Therapeutics Ltd. was founded in 2003 and is headquartered in Hamilton, Bermuda. Altamira Therapeutics is traded on NASDAQ Exchange in the United States. For more info on Altamira Therapeutics please contact the company at 441 295 5950 or go to https://altamiratherapeutics.com.

Altamira Therapeutics Investment Alerts

Altamira Therapeutics Upcoming and Recent Events

Altamira Largest EPS Surprises

View All Earnings Estimates

Altamira Stock Institutional Investors

Note, although Altamira Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Altamira Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.59 M.

Altamira Profitablity

Management Efficiency

Altamira Therapeutics has return on total asset (ROA) of (0.5715) % which means that it has lost $0.5715 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.6878) %, meaning that it created substantial loss on money invested by shareholders. Altamira Therapeutics' management efficiency ratios could be used to measure how well Altamira Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to drop to -2.01. In addition to that, Return On Capital Employed is likely to grow to -0.83. At this time, Altamira Therapeutics' Debt To Assets are very stable compared to the past year. As of the 28th of November 2024, Asset Turnover is likely to grow to 0.05, while Total Assets are likely to drop about 7.3 M.

Technical Drivers

As of the 28th of November, Altamira Therapeutics shows the Standard Deviation of 4.68, mean deviation of 3.49, and Risk Adjusted Performance of (0.16). Altamira Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Altamira Therapeutics Price Movement Analysis

Altamira Therapeutics Insider Trading Activities

Altamira Therapeutics Outstanding Bonds

Altamira Therapeutics Predictive Daily Indicators

Altamira Therapeutics Forecast Models

Altamira Therapeutics' time-series forecasting models are one of many Altamira Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Altamira Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Altamira Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Altamira shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Altamira Therapeutics. By using and applying Altamira Stock analysis, traders can create a robust methodology for identifying Altamira entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altamira Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Altamira Stock, please use our How to Invest in Altamira Therapeutics guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Altamira Therapeutics. If investors know Altamira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Altamira Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Altamira Therapeutics is measured differently than its book value, which is the value of Altamira that is recorded on the company's balance sheet. Investors also form their own opinion of Altamira Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Altamira Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Altamira Therapeutics' market value can be influenced by many factors that don't directly affect Altamira Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Altamira Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Altamira Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Altamira Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.